Literature DB >> 8321832

Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state.

S Yoshioka1, Y Aso, K Izutsu, T Terao.   

Abstract

Aggregates formed during storage of freeze-dried beta-galactosidase were compared with those formed in solutions. Freeze-dried beta-galactosidase aggregated during storage in the presence of moisture, producing a protein precipitate which was soluble in guanidine hydrochloride solution but not in buffer solution. The protein precipitate dissolved in guanidine solution exhibited a large molecular size by high-performance size exclusion chromatography and converted to proteins of original size in the presence of dithiothreitol. It is suggested that the aggregation involves chemical interaction via covalent disulfide bonding. In contrast, beta-galactosidase in aqueous solution aggregated without formation of protein precipitates. Soluble aggregates were converted to proteins of original size in guanidine solution without dithiothreitol, suggesting noncovalent bonding. The difference in aggregation behavior may be ascribed to the difference in the water:protein ratio. We propose that inactivation of beta-galactosidase is due to formation of thermally denatured (unfolded) protein, which aggregates dependent on the water:protein ratio, either via noncovalent interactions at a high water:protein ratio in solution or via covalent interaction at a low water:protein ratio in the freeze-dried state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321832     DOI: 10.1023/a:1018951530927

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Stability of ribonuclease A in solution and the freeze-dried state.

Authors:  M W Townsend; P P DeLuca
Journal:  J Pharm Sci       Date:  1990-12       Impact factor: 3.534

2.  Nature of aggregates formed during storage of freeze-dried ribonuclease A.

Authors:  M W Townsend; P P DeLuca
Journal:  J Pharm Sci       Date:  1991-01       Impact factor: 3.534

3.  Lyophilized formulations of recombinant tumor necrosis factor.

Authors:  M S Hora; R K Rana; F W Smith
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A.

Authors:  M W Townsend; P P DeLuca
Journal:  J Parenter Sci Technol       Date:  1988 Nov-Dec

5.  Stability of beta-galactosidase, a model protein drug, is related to water mobility as measured by 17O nuclear magnetic resonance (NMR).

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

6.  Moisture-induced aggregation of lyophilized proteins in the solid state.

Authors:  W R Liu; R Langer; A M Klibanov
Journal:  Biotechnol Bioeng       Date:  1991-01-20       Impact factor: 4.530

7.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  7 in total
  9 in total

1.  Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

2.  Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.

Authors:  Saradha Chandrasekhar; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2015-01-28       Impact factor: 3.534

3.  The effect of salts on the stability of beta-galactosidase in aqueous solution, as related to the water mobility.

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

4.  Is stability prediction possible for protein drugs? Denaturation kinetics of beta-galactosidase in solution.

Authors:  S Yoshioka; Y Aso; K Izutsu; S Kojima
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

Review 5.  Recent mass spectrometry-based techniques and considerations for disulfide bond characterization in proteins.

Authors:  Jude C Lakbub; Joshua T Shipman; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2017-12-18       Impact factor: 4.142

6.  Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.

Authors:  A Braun; J Alsenz
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

7.  Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry.

Authors:  R L Remmele; N S Nightlinger; S Srinivasan; W R Gombotz
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

8.  A new strategy for enhancing the stability of lyophilized protein: the effect of the reconstitution medium on keratinocyte growth factor.

Authors:  M Z Zhang; J Wen; T Arakawa; S J Prestrelski
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

9.  Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity.

Authors:  Amal Thamri; Myriam Létourneau; Alex Djoboulian; David Chatenet; Eric Déziel; Annie Castonguay; Jonathan Perreault
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.